Context Capital Management »

Sarepta Therapeutics shares owned by Context Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics shares owned by Context Capital Management from 13F filings

Historical chart of Context Capital Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Context Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $9.6M 8.0k 1202.13
2022-12-31 $6.4M 5.5k 1157.45
2022-09-30 $10M 10k 1029.50

More positions owned by Context Capital Management

Beauty Health Note 1.25% 10/1 (Principal)
Peloton Interactive Note 2/1 (Principal)
Microstrategy Note 2/1 (Principal)
Wayfair Note 1.000% 8/1 (Principal)
3d Sys Corp Del Note 11/1 (Principal)
Alphatec Hldgs Note 0.750% 8/0 (Principal)
Affirm Hldgs Note 11/1 (Principal)
Upstart Hldgs Note 0.250% 8/1 (Principal)
Wayfair Note 0.625%10/0 (Principal)
Travere Therapeutics Note 2.250% 3/0 (Principal)
Porch Group Note 6.75% 10/1 (Principal)
Sea Note 0.250% 9/1 (Principal)
Groupon Note 1.125% 3/1 (Principal)
Marathon Digital Holdings In Note 1.000%12/0 (Principal)
Xometry Note 1.000% 2/0 (Principal)

View all positions for Context Capital Management